Sign In

Greg Went

Founder, Board Member, and Advisor

Greg Went is an experienced entrepreneur and pharmaceutical industry veteran currently serving as the CEO and Chairman of Reflexion Pharmaceuticals since 2021.12 He has a strong background in biotechnology and has founded multiple successful startups in the life sciences.4

Went earned his BS in Chemical Engineering from Carnegie Mellon University in 1985 and his PhD in Chemical Engineering from the University of California, Berkeley in 1990.14

Throughout his career, Greg Went has held several key positions:

  1. Co-founder and COO of CuraGen Corporation (1991-1999)4
  2. COO and Board Member at DNA Sciences (2000-2001)4
  3. Co-founder and Board Member of Tethys Bioscience (2003-2013)4
  4. Founder, CEO, and Chairman of Adamas Pharmaceuticals (2004-2019)4
  5. Co-founder and Chairman of SynaVir (2020-2022)4

At Reflexion Pharmaceuticals, Went is leading the development of D-protein therapeutics, an entirely new class of drugs that are designed to be extremely specific in targeting while resisting enzymatic breakdown in the body.23

Greg Went is known for his focus on developing innovative medicines that significantly improve patient care, emphasizing the need for products that are "a factor of two to ten times better than the standard of care".23

Highlights

Jul 28 · theorg.com
Greg Went - CEO and Chairman at Reflexion Pharmaceuticals
Alum spotlight: Greg Went - Chemical Engineering
Alum spotlight: Greg Went - Chemical Engineering
Nov 18 · bbh.berkeley.edu
Tenant Spotlight: Reflexion Pharmaceuticals & The Mirror World of D ...
Jan 1 · rocketreach.co
Greg Went Email & Phone Number | Dextera Biosciences Chief ...
Greg Went Email & Phone Number | Dextera Biosciences Chief ...

Related Questions

What inspired Greg Went to transition from Adamas Pharmaceuticals to Reflexion Pharmaceuticals?
How does Greg Went's background in chemical engineering influence his approach at Reflexion Pharmaceuticals?
What are the main challenges Greg Went sees for Reflexion Pharmaceuticals in the biotech industry?
How does Reflexion Pharmaceuticals' D-protein therapeutics differ from traditional monoclonal antibodies?
What role does Jack Nguyen play at Reflexion Pharmaceuticals, and how did they collaborate with Greg Went in the past?
Greg Went
Greg Went, photo 1
Greg Went, photo 2
Add to my network

Location

San Francisco Bay Area